Jin-Won Chung

2.1k total citations
70 papers, 1.2k citations indexed

About

Jin-Won Chung is a scholar working on Epidemiology, Infectious Diseases and Molecular Medicine. According to data from OpenAlex, Jin-Won Chung has authored 70 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Epidemiology, 37 papers in Infectious Diseases and 11 papers in Molecular Medicine. Recurrent topics in Jin-Won Chung's work include SARS-CoV-2 and COVID-19 Research (13 papers), COVID-19 Clinical Research Studies (13 papers) and Respiratory viral infections research (13 papers). Jin-Won Chung is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (13 papers), COVID-19 Clinical Research Studies (13 papers) and Respiratory viral infections research (13 papers). Jin-Won Chung collaborates with scholars based in South Korea, United States and Puerto Rico. Jin-Won Chung's co-authors include Yang Soo Kim, Sang‐Ho Choi, Seong‐Ho Choi, Jiso Ryu, Min‐Chul Kim, Nam Joong Kim, Sang‐Oh Lee, Tae Hyong Kim, Jun-Hee Woo and Yee Gyung Kwak and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and Journal of Clinical Microbiology.

In The Last Decade

Jin-Won Chung

68 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jin-Won Chung South Korea 18 526 446 333 156 151 70 1.2k
B. Pilmis France 20 339 0.6× 498 1.1× 324 1.0× 156 1.0× 156 1.0× 85 1.1k
Matthieu Lafaurie France 21 766 1.5× 748 1.7× 295 0.9× 184 1.2× 170 1.1× 64 1.5k
Karim Khader United States 15 543 1.0× 422 0.9× 304 0.9× 244 1.6× 105 0.7× 52 1.0k
Rupali Jain United States 17 412 0.8× 419 0.9× 335 1.0× 144 0.9× 322 2.1× 55 1.1k
Grace C. Lee United States 17 339 0.6× 328 0.7× 271 0.8× 201 1.3× 152 1.0× 41 1.1k
Sorana Segal‐Maurer United States 22 707 1.3× 593 1.3× 466 1.4× 162 1.0× 254 1.7× 63 1.6k
Hae Suk Cheong South Korea 18 289 0.5× 430 1.0× 350 1.1× 140 0.9× 113 0.7× 52 1.0k
Eui Chong Kim South Korea 19 449 0.9× 472 1.1× 254 0.8× 110 0.7× 69 0.5× 73 1.1k
R. Lepeule France 17 335 0.6× 410 0.9× 361 1.1× 196 1.3× 203 1.3× 69 1.0k
Daniel A. Green United States 19 599 1.1× 569 1.3× 185 0.6× 131 0.8× 87 0.6× 52 1.3k

Countries citing papers authored by Jin-Won Chung

Since Specialization
Citations

This map shows the geographic impact of Jin-Won Chung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jin-Won Chung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jin-Won Chung more than expected).

Fields of papers citing papers by Jin-Won Chung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jin-Won Chung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jin-Won Chung. The network helps show where Jin-Won Chung may publish in the future.

Co-authorship network of co-authors of Jin-Won Chung

This figure shows the co-authorship network connecting the top 25 collaborators of Jin-Won Chung. A scholar is included among the top collaborators of Jin-Won Chung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jin-Won Chung. Jin-Won Chung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Park, Ji Young, Seong‐Ho Choi, Yong Kwan Lim, et al.. (2025). The Humoral Immune Response Against COVID-19 Through Vaccination in Hemodialysis Patients. Vaccines. 13(2). 170–170.
2.
3.
Lim, Yong Kwan, et al.. (2022). Prevalence of Anti-PF4 Antibodies After First and Second ChAdOx1 nCoV-19 Vaccinations in Women With Adverse Events: A Brief Report and Literature Review. Annals of Laboratory Medicine. 43(3). 299–302. 1 indexed citations
4.
Choi, Seong‐Ho, et al.. (2022). SARS-CoV-2 Omicron escapes mRNA vaccine booster-induced antibody neutralisation in patients with autoimmune rheumatic diseases: an observational cohort study. Annals of the Rheumatic Diseases. 81(11). 1585–1593. 12 indexed citations
5.
Kim, Min‐Chul, et al.. (2021). Ten-Year Prevalence Trends of Phenotypically Identified Community-Associated Methicillin-Resistant Staphylococcus aureus Strains in Clinical Specimens. Annals of Laboratory Medicine. 41(4). 386–393. 2 indexed citations
6.
Chung, Jin-Won, et al.. (2021). Clinical Pathway for Emergency Brain Surgery during COVID-19 Pandemic and Its Impact on Clinical Outcomes. Journal of Korean Medical Science. 36(2). e16–e16. 5 indexed citations
7.
Chung, Jin-Won, et al.. (2021). Hip Fracture Management during the COVID-19 Pandemic in South Korea. Clinics in Orthopedic Surgery. 13(4). 474–474. 10 indexed citations
8.
Park, Ji Young, et al.. (2021). Systemic Adverse Events and Use of Antipyretics Predict the Neutralizing Antibody Positivity Early after the First Dose of ChAdOx1 Coronavirus Disease Vaccine. Journal of Clinical Medicine. 10(13). 2844–2844. 14 indexed citations
9.
Suh, Hyeon Jeong, Eun Young Heo, Hyun Woo Lee, et al.. (2020). Clinical Characteristics of COVID-19: Clinical Dynamics of Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infection Detected by Early Active Surveillance. Journal of Korean Medical Science. 35(32). e297–e297. 18 indexed citations
10.
Kim, Min‐Chul, Seon‐Ok Kim, Su Hyun Kim, et al.. (2020). Efficacy and Safety of Cystatin C-Guided Renal Dose Adjustment of Cefepime Treatment in Hospitalized Patients with Pneumonia. Journal of Clinical Medicine. 9(9). 2803–2803. 3 indexed citations
11.
Kweon, Oh Joo, Yong Kwan Lim, Hye Ryoun Kim, et al.. (2020). Antibody kinetics and serologic profiles of SARS-CoV-2 infection using two serologic assays. PLoS ONE. 15(10). e0240395–e0240395. 15 indexed citations
12.
Choi, Won Suk, Seong Yeol Ryu, Jacob Lee, et al.. (2018). Safety and Effectiveness of Peramivir in Korean Adult Influenza Patients: Prospective Observational Study Based on Post-Marketing Surveillance Data. Journal of Korean Medical Science. 33(32). e212–e212. 4 indexed citations
13.
Choi, Seong-Ho, et al.. (2018). Changes in the early mortality of adult patients with carbapenem-resistant Acinetobacter baumannii bacteremia during 11 years at an academic medical center. Journal of Infection and Chemotherapy. 25(1). 6–11. 11 indexed citations
14.
Choi, Seong‐Ho, et al.. (2017). Early administration of neuraminidase inhibitors in adult patients hospitalized for influenza does not benefit survival: a retrospective cohort study. European Journal of Clinical Microbiology & Infectious Diseases. 36(9). 1673–1677. 4 indexed citations
15.
Choi, Seong‐Ho, Jin-Won Chung, Heungsup Sung, et al.. (2012). Impact of Penicillin Nonsusceptibility on Clinical Outcomes of Patients with Nonmeningeal Streptococcus pneumoniae Bacteremia in the Era of the 2008 Clinical and Laboratory Standards Institute Penicillin Breakpoints. Antimicrobial Agents and Chemotherapy. 56(9). 4650–4655. 15 indexed citations
16.
Lee, Eun Jung, Jin-Won Chung, Sang‐Ho Choi, Yang Soo Kim, & Jun Hee Woo. (2009). Forefront of Diagnosis and Treatment of Deep-steam Mycology in Korea- Rhinoorbitocerebral Zygomycosis. Nippon Ishinkin Gakkai Zasshi. 50(4). 229–233. 2 indexed citations
17.
Chung, Jin-Won, et al.. (2008). A case of hypersensitivity vasculitis after influenza vaccination. The Korean Journal of Internal Medicine. 74(5). 476–477. 1 indexed citations
18.
Choi, Sang‐Ho, Yee Gyung Kwak, Jin-Won Chung, et al.. (2008). Risk factors for the acquisition of carbapenem-resistant Escherichia coli among hospitalized patients. Diagnostic Microbiology and Infectious Disease. 62(4). 402–406. 56 indexed citations
19.
Kwak, Yee Gyung, Sang‐Ho Choi, Eun Ju Choo, et al.. (2005). Risk Factors for the Acquisition of Carbapenem-Resistant Klebsiella pneumoniae among Hospitalized Patients. Microbial Drug Resistance. 11(2). 165–169. 81 indexed citations
20.
Choi, Sang‐Ho, Yang Soo Kim, In‐Gyu Bae, et al.. (2002). The possible role of cerebrospinal fluid adenosine deaminase activity in the diagnosis of tuberculous meningitis in adults. Clinical Neurology and Neurosurgery. 104(1). 10–15. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026